Aberrant Functional Connectome in Neurologically Asymptomatic Patients with End-Stage Renal Disease

被引:35
|
作者
Ma, Xiaofen [1 ]
Jiang, Guihua [2 ]
Li, Shumei [2 ]
Wang, Jinhui [3 ,4 ]
Zhan, Wenfeng [2 ]
Zeng, Shaoqing [2 ]
Tian, Junzhang [2 ]
Xu, Yikai [1 ]
机构
[1] Southern Medial Univ, Nanfang Hosp, Dept Med Imaging Ctr, Guangzhou, Guangdong, Peoples R China
[2] Guangdong 2 Prov Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China
[3] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China
[4] Zhejiang Key Lab Res Assessment Cognit Impairment, Hangzhou, Zhejiang, Peoples R China
来源
PLOS ONE | 2015年 / 10卷 / 03期
基金
中国国家自然科学基金;
关键词
CHRONIC KIDNEY-DISEASE; CEREBRAL-BLOOD-FLOW; GRAPH-THEORETICAL ANALYSIS; COMPLEX BRAIN NETWORKS; RESTING-STATE FMRI; DEFAULT-MODE; COGNITIVE FUNCTION; SMALL-WORLD; MODULAR ORGANIZATION; CONNECTIVITY MRI;
D O I
10.1371/journal.pone.0121085
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purpose This study aimed to investigate the topological organization of intrinsic functional brain networks in patients with end-stage renal disease (ESRD). Materials and Methods Resting-state functional MRI data were collected from 22 patients with ESRD (16 men, 18-61 years) and 29age- and gender-matched healthy controls (HCs, 19 men, 32-61 years). Whole-brain functional networks were obtained by calculating the interregional correlation of low-frequency fluctuations in spontaneous brain activity among 1,024 parcels that cover the entire cerebrum. Weighted graph-based models were then employed to topologically characterize these networks at different global, modular and nodal levels. Results Compared to HCs, the patients exhibited significant disruption in parallel information processing over the whole networks (P < 0.05). The disruption was present in all the functional modules (default mode, executive control, sensorimotor and visual networks) although decreased functional connectivity was observed only within the default mode network. Regional analysis showed that the disease disproportionately weakened nodal efficiency of the default mode components and tended to preferentially affect central or hub-like regions. Intriguingly, the network abnormalities correlated with biochemical hemoglobin and serum calcium levels in the patients. Finally, the functional changes were substantively unchanged after correcting for gray matter atrophy in the patients. Conclusion Our findings provide evidence for the disconnection nature of ESRD's brain and therefore have important implications for understanding the neuropathologic substrate of the disease from disrupted network organization perspective.
引用
收藏
页数:21
相关论文
共 50 条
  • [31] Butyrate production in patients with end-stage renal disease
    Terpstra, Matty L.
    Sinnige, Marjan J.
    Hugenholtz, Floor
    Peters-Sengers, Hessel
    Remmerswaal, Ester B. M.
    Geerlings, Suzanne E.
    Bemelman, Frederike J.
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2019, 12 : 87 - 101
  • [32] Safety of Regadenoson in Patients With End-Stage Renal Disease
    Aljaroudi, Wael
    Hermann, Danny
    Hage, Fadi
    Iskandrian, Ami E.
    CIRCULATION, 2009, 120 (18) : S493 - S493
  • [33] PANCREATITIS IN PATIENTS WITH END-STAGE RENAL-DISEASE
    PADILLA, B
    POLLAK, VE
    PESCE, A
    KANT, KS
    GILINSKY, NH
    DEDDENS, JA
    MEDICINE, 1994, 73 (01) : 8 - 20
  • [34] Glymphatic Dysfunction in Patients With End-Stage Renal Disease
    Heo, Chang Min
    Lee, Won Ho
    Park, Bong Soo
    Lee, Yoo Jin
    Park, Sihyung
    Kim, Yang Wook
    Lee, Dong Ah
    Yoo, Byeong Cheol
    Park, Kang Min
    FRONTIERS IN NEUROLOGY, 2022, 12
  • [35] Finger Gangrene in End-Stage Renal Disease Patients
    Ahmed, R.
    Shukla, N.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2023, 71 : S15 - S15
  • [36] Cancer management in patients with end-stage renal disease
    Eneman, Jonathan D.
    Philips, George K.
    ONCOLOGY-NEW YORK, 2005, 19 (09): : 1199 - 1212
  • [37] Pharmacokinetics of rosiglitazone in patients with end-stage renal disease
    Thompson-Culkin, K
    Zussman, B
    Miller, AK
    Freed, MI
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2002, 30 (04) : 391 - 399
  • [38] End-stage renal disease in patients with rheumatoid arthritis
    Paudyal, Sunita
    Yang, Frances M.
    Rice, Christopher
    Chen, Chen-Chun
    Skelton, Michael
    Bethel, Monique
    Brown, Shilpa
    Nahman, Norris Stanley, Jr.
    Carbone, Laura
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2017, 46 (04) : 418 - 422
  • [39] Quality of life in end-stage renal disease patients
    Valderrábano, F
    Jofre, R
    López-Gómez, JM
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (03) : 443 - 464
  • [40] Pulmonary hypertension in patients with end-stage renal disease
    Yigla, M
    Nakhoul, F
    Sabag, A
    Tov, N
    Gorevich, B
    Abassi, Z
    Reisner, SA
    CHEST, 2003, 123 (05) : 1577 - 1582